1UTG
| REFINEMENT OF THE C2221 CRYSTAL FORM OF OXIDIZED UTEROGLOBIN AT 1.34 ANGSTROMS RESOLUTION | 分子名称: | UTEROGLOBIN | 著者 | Morize, I, Surcouf, E, Vaney, M.C, Buehner, M, Mornon, J.P. | 登録日 | 1989-04-03 | 公開日 | 1989-10-15 | 最終更新日 | 2017-11-29 | 実験手法 | X-RAY DIFFRACTION (1.34 Å) | 主引用文献 | Refinement of the C222(1) crystal form of oxidized uteroglobin at 1.34 A resolution. J.Mol.Biol., 194, 1987
|
|
4A6L
| beta-tryptase inhibitor | 分子名称: | 1-{3-[1-({5-[(2-fluorophenyl)ethynyl]furan-2-yl}carbonyl)piperidin-4-yl]phenyl}methanamine, TRYPTASE ALPHA/BETA-1 | 著者 | Mathieu, M, Maignan, S. | 登録日 | 2011-11-04 | 公開日 | 2012-01-25 | 最終更新日 | 2024-05-01 | 実験手法 | X-RAY DIFFRACTION (2.05 Å) | 主引用文献 | Structure-Based Library Design and the Discovery of a Potent and Selective Mast Cell Beta-Tryptase Inhibitor as an Oral Therapeutic Agent. Bioorg.Med.Chem.Lett., 22, 2012
|
|
3VFE
| Virtual Screening and X-Ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group | 分子名称: | 4-{[(3R)-3-{[(7-methoxynaphthalen-2-yl)sulfonyl](thiophen-3-ylmethyl)amino}-2-oxopyrrolidin-1-yl]methyl}thiophene-2-carboximidamide, Kallikrein-6 | 著者 | Chen, X, Zhang, Y, Xia, T, Wang, R. | 登録日 | 2012-01-09 | 公開日 | 2012-11-21 | 最終更新日 | 2024-05-01 | 実験手法 | X-RAY DIFFRACTION (1.88 Å) | 主引用文献 | Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group. Acs Med.Chem.Lett., 3, 2012
|
|